Moleculin Biotech, Inc. (MBRX) Gross margin
Moleculin Biotech, Inc. (MBRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to MBRXSource: SEC XBRL filings · For reference only · Not investment advice
More MBRX financial trends
MBRX RevenueMBRX Net incomeMBRX Net marginMBRX Gross profitMBRX Operating incomeMBRX Operating marginMBRX Operating cash flowMBRX Free cash flowMBRX Capital expendituresMBRX Return on equityMBRX Stock buybacksMBRX Dividends paidMBRX Total assetsMBRX Total liabilitiesMBRX Shareholders’ equityMBRX overview →